14,988+ Questions · 21 Subjects · Free to Practice

The first CRISPR-based therapy to gain regulatory approval, Casgevy, was approved by the UK’s MHRA in November 2023 and the US FDA in December 2023, to treat which disease?

1. The first CRISPR-based therapy to gain regulatory approval, Casgevy, was approved by the UK’s MHRA in November 2023 and the US FDA in December 2023, to treat which disease?

 

Beyond the answer

    Leave a Reply

    Discover more from MCQ Questions

    Subscribe now to keep reading and get access to the full archive.

    Continue reading